TickerFacts.

Nexgel, Inc. (NXGL): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$2.90M
Year ended 2025-12-31
-$4.25M
Trailing 12 months to 2026-06-30
2018-12-31: -$1.57M2019-12-31: -$1.86M2020-12-31: -$2.21M2021-12-31: -$2.46M2022-12-31: -$3.24M2023-12-31: -$3.25M2024-12-31: -$3.12M2025-12-31: -$2.90M-$2.90M
2018-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$2.90Mn/m2026-03-31, From 2025-01-01
2024-12-31-$3.12Mn/m2026-03-31, From 2024-01-01
2023-12-31-$3.25Mn/m2025-03-27, From 2023-01-01
2022-12-31-$3.24Mn/m2024-04-10, From 2022-01-01
2021-12-31-$2.46Mn/m2023-03-28, From 2021-01-01
2020-12-31-$2.21Mn/m2022-03-21, From 2020-01-01
2019-12-31-$1.86Mn/m2021-03-31, From 2019-01-01
2018-12-31-$1.57Mn/a2020-04-03, From 2018-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Nexgel, Inc. (NXGL)2025-12-31-$2.90Mn/m
Medinotec Inc. (MDNC)2026-02-28$1.18M-64.0%
Neuroone Medical Technologies Corp (NMTC)2025-09-30-$3.96Mn/m
InspireMD, Inc. (NSPR)2025-12-31$426.39M+73.0%
Allurion Technologies, Inc. (ALUR)2025-12-31-$29.17Mn/m
Beyond Air, Inc. (XAIR)2026-03-31-$25.94Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$18.59Mn/m
Nephros Inc (NEPH)2025-12-31$1.29M+812.1%
INVO Fertility, Inc. (IVF)2025-12-31-$6.56Mn/m

Compare NXGL, MDNC, NMTC, NSPR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗